Goose, a leading innovator of Business Reengineering Solutions for global pharmaceutical industry, has developed Procon Tracker, a ready to deploy 2D Bar Code and Unique Identification solution in India.

The Track and Trace solution would now help pharma companies to meet the new regulatory packaging guideline, detect counterfeit and protect their brand reputation. The company is in talks with its existing and potential customers and expects wide acceptance and adoption Procon Tracker in the industry.

Procon Tracker is a new addition to Goose' wide range of Procon solutions adopted by several leading global pharma companies to increase business processes efficiency. It features a robust encrypted serialization and package authentication capability designed to ensure consumer safety, reduce counterfeiting and diversion and meet multiple stakeholder expectations throughout the product supply chain from the point of manufacturing to consumer end.

The CFR Part 11 compliant Procon Tracker supports pedigree which is an electronic record keeping requirement and is capable of multi printer interface. It also supports automated and manual lines with added competency to work offline when there are no bar code capable printers. Further, it also has an ERP integration along with a module to enable verification through SMS, Web or IVR. The solution can generate billions of Unique Numbers with minimum 6 characters that is expandable based on customer need.

Other features of Procon Tracker include proprietary algorithm that considers several parameters specific to company, batch and computer. Procon™ Tracker is scalable and has quick response time for generation and validation of serial numbers. Procon Tracker supports GS1 standards.

“The recent directive from the government to implement track and trace automatic identification process to offset counterfeits opens up an opportunity for our product Procon Tracker. We found the Pharma Industry is eager to meet the new regulatory compliance norms deadline without disrupting packaging quality process and Procon Tracker is designed precisely to meet these expectations,” stated Deb Pattnaik, founder, Goose.

Counterfeit drugs entering the supply chain is a growing problem around the world. Patient safety is crucially important within the healthcare and pharmaceutical industries, apart from the fact that counterfeiting erodes bottom lines of most pharmaceutical companies, he added.

The Centre for Medicines in the Public Interest estimates that globally, counterfeit pharmaceutical commerce will grow to become 16 per cent of the aggregate size of the legitimate industry, a six percentage-point increase from 2004. This illegal business will generate $ 75 billion in revenues for its owners in 2010, a 92 per cent increase from 2005.

Goose offers a wide range of pharma industry specific solutions such as Artwork, Project, Consumable Regulatory Affairs Management and Portfolio Management Solutions. Currently, its customers include large Indian and multinational pharmaceutical companies.